KCT0000139已完成未知
The reversal of cisatracurium induced neuromuscular block using the subjective neuromuscular monitoring
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 51
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 18(Year) 至 64(Year)（—）
- 性别
- All
入选标准
- •18-64 yrs old, ASA 1,2
排除标准
- •Body weight over 130% of IBW, musculoneuronal disease, drug that can affect on neunomuscular transmission. Renal or hepatic disease, cardiac pacemaker
研究者
相似试验
尚未招募
不适用
Effect of Muscle paralyzing drug(CISATRACURIUM)on anti-fits/seizure drug (LEVETIRACETAM)in patients undergoing neurosurgery.CTRI/2022/12/048574M S Ramaiah Medical college
尚未招募
4 期
Study to find incidence of residual neuromuscular paralysis by using neuromuscular monitor after various doses of neostigmine reversal agentCTRI/2020/08/027270SMS Medical College
已完成
不适用
euromuscular blocking properties of cisatracurium: A comparative study in breast cancer patients with or without neoadjuvant chemotherapyCTRI/2019/01/017027Rajiv Gandhi Cancer Institute and Research Centre100
尚未招募
4 期
Is reversal of muscle paralysis necessary after giving blocking drugs?CTRI/2016/01/006553Sir Ganga Ram Hospital100
进行中（未招募）
不适用
Reversal of neuromuscular block using sugammadexThe effect of sugammadex dose on residual neuromuscular blockade willbe investigated, therefore patients suffering from various conditionsundergoing surgery in general anaesthesia with muscle relaxation willbe included in the study.EUCTR2013-004666-34-HUniversity of Debrecen, Medical and Health Science Center, Department of Anaesthesiology and Intensive Therapy